BRADY TODD C (President and CEO) purchased 17.0% of their position (250K shares) of ALDEYRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $418.4K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/5/2026ACC: 0001193125-26-259637
DirectorOfficer· President and CEO
Since Mar 2019
+250K
Net shares
Net buyer
$418.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
250K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
$1.67
Trade value
$418.45K
% of position
17.0%
6/3/2026
1.47M→1.72M
Total
Net shares
+250K
Net value
$418.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2026 | P · Purchase | +250K | $1.67 | $418.45K | 17.0% | 1.47M | 1.72M |
| Total | +250K | $418.45K | ||||||
Derivative Transactions0
No derivative transactions reported